203 related articles for article (PubMed ID: 26662316)
1. MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
Fan JY; Yang Y; Xie JY; Lu YL; Shi K; Huang YQ
Tumour Biol; 2016 May; 37(5):6855-60. PubMed ID: 26662316
[TBL] [Abstract][Full Text] [Related]
2. miR-495 mediates metabolic shift in glioma cells via targeting Glut1.
Nie S; Li K; Huang Y; Hu Q; Gao X; Jie S
J Craniofac Surg; 2015 Mar; 26(2):e155-8. PubMed ID: 25759932
[TBL] [Abstract][Full Text] [Related]
3. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
4. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
Chen X; Yu J; Tian H; Shan Z; Liu W; Pan Z; Ren J
J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
Teng Y; Zhang Y; Qu K; Yang X; Fu J; Chen W; Li X
Oncotarget; 2015 Dec; 6(38):40799-814. PubMed ID: 26512921
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
Zhao X; Lu C; Chu W; Zhang B; Zhen Q; Wang R; Zhang Y; Li Z; Lv B; Li H; Liu J
Tumour Biol; 2017 May; 39(5):1010428317706215. PubMed ID: 28488541
[TBL] [Abstract][Full Text] [Related]
9. miR-186 regulates glycolysis through Glut1 during the formation of cancer-associated fibroblasts.
Sun P; Hu JW; Xiong WJ; Mi J
Asian Pac J Cancer Prev; 2014; 15(10):4245-50. PubMed ID: 24935378
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-340 Mediates Metabolic Shift in Oral Squamous Cell Carcinoma by Targeting Glucose Transporter-1.
Xu P; Li Y; Zhang H; Li M; Zhu H
J Oral Maxillofac Surg; 2016 Apr; 74(4):844-50. PubMed ID: 26541225
[TBL] [Abstract][Full Text] [Related]
11. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
[TBL] [Abstract][Full Text] [Related]
12. miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.
Santasusagna S; Moreno I; Navarro A; Muñoz C; Martinez F; Hernández R; Castellano JJ; Monzo M
Clin Transl Oncol; 2018 Sep; 20(9):1161-1167. PubMed ID: 29374351
[TBL] [Abstract][Full Text] [Related]
13. miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.
Han RL; Wang FP; Zhang PA; Zhou XY; Li Y
Neoplasma; 2017; 64(2):244-252. PubMed ID: 28043152
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
Fu X; Cui Y; Yang S; Xu Y; Zhang Z
Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene.
Li LQ; Yang Y; Chen H; Zhang L; Pan D; Xie WJ
Cancer Biomark; 2016 Jun; 17(1):75-81. PubMed ID: 27314295
[TBL] [Abstract][Full Text] [Related]
17. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
Wu DD; Li XS; Meng XN; Yan J; Zong ZH
Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
